GlassScriptPhysician profile
Karen Foti
NPI 1750493383
$590.17
in general payments reported to CMS, 2019-2025
14 companies · $284 in 2025
The $284 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.34 · 2020: $20.45 · 2021: $22.14 · 2022: $52.98 · 2023: $39.82 · 2024: $94.03 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $157.03 | 2025 | Dupixent |
| Cranial Technologies, INC | $67.71 | 2024-2025 | Doc Band |
| Kyowa Kirin, INC. | $63.86 | 2024-2025 | Crysvita |
| Merck Sharp & Dohme LLC | $60.77 | 2019-2025 | Vaqta, Gardasil 9, M-M-R II |
| Sanofi Pasteur INC. | $52.22 | 2022-2025 | |
| Pfizer INC. | $30.57 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $28.54 | 2025 | Zoryve |
| Verrica Pharmaceuticals INC. | $23.14 | 2023 | Ycanth |
| Alkermes, INC. | $22.14 | 2021 | |
| Glaxosmithkline, LLC. | $20.45 | 2020 | |
| Ironshore Pharmaceuticals INC. | $18.65 | 2019 | |
| Organon LLC | $16.68 | 2023 | Nexplanon |
| Horizon Therapeutics Plc | $16.25 | 2019 | |
| Tris Pharma INC | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Foti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.